Yuichiro Nawa - Concepedia

Author

Yuichiro Nawa

Also Known As

Kiyohito Hayashi, Koichi Nakase, Michihiro Hidaka, Satoshi Iyama, Takashi Saito, Y Nawa, Yoshinobu Maeda, Yuichiro Nawa, Yuichiro Nawa

Publications

733

Citations

H-Index

Concepts

All Affiliations

Ehime Prefectural Central Hospital Okayama University Kanagawa Prefectural Hospital Organization The University of Tokyo Okayama University Hospital

About

Yuichiro Nawa is an author at Ehime Prefectural Central Hospital specializing in medicine, hematology, and transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	193
2	Health Sciences	3	3	105
3	Blood Transplantation	2	2	92
4	Allergy	1	1	18
5	Emergency Medicine	1	1	13

Yuichiro Nawa

Publications

485

Citations

H-Index

Page 1

	Year	Citations
Comparison of Allogeneic Hematopoietic Cell Transplantation and Chemotherapy in Elderly Patients with Non-M3 Acute Myelogenous Leukemia in First Complete Remission Saiko Kurosawa, Takuhiro Yamaguchi, Naoyuki Uchida, Biology of Blood and Marrow Transplantation Hematological MalignancyFirst Complete RemissionTransplantationMarrow TransplantationElderly Patients	2010	75
A Markov decision analysis of allogeneic hematopoietic cell transplantation versus chemotherapy in patients with acute myeloid leukemia in first remission Saiko Kurosawa, Takuhiro Yamaguchi, Shuichi Miyawaki, Blood	2010	50
Dose-adjusted EPOCH chemotherapy for untreated peripheral T-cell lymphomas: a multicenter phase II trial of West-JHOG PTCL0707 Yoshinobu Maeda, Hisakazu Nishimori, Isao Yoshida, Haematologica	2017	40
The utility of positron emission tomography/computed tomography in the staging of extranodal natural killer/T-cell lymphoma Hideaki Fujiwara, Yoshinobu Maeda, Yuichiro Nawa, European Journal Of Haematology	2011	36
Feasibility of the imatinib stop study in the Japanese clinical setting: delightedly overcome CML expert stop TKI trial (DOMEST Trial) Shin Fujisawa, Yasunori Ueda, Kensuke Usuki, International Journal of Clinical Oncology Domest TrialClinical TranslationImatinib Stop StudyMedicineClinical Endpoint	2018	36
Maximum standard uptake value of 18F-fluorodeoxyglucose positron emission tomography is a prognostic factor for progression-free survival of newly diagnosed patients with diffuse large B cell lymphoma Yukihiro Miyazaki, Yuichiro Nawa, Masao Miyagawa, Annals of Hematology	2012	35
Impacts of graft-versus-host disease on outcomes after allogeneic hematopoietic stem cell transplantation for chronic myelomonocytic leukemia: A nationwide retrospective study Hidehiro Itonaga, Masako Iwanaga, Kazunari Aoki, Leukemia Research Graft-versus-host DiseaseTransplantationMarrow TransplantationChronic Myelomonocytic LeukemiaStem Cell Transplantation	2015	34
Prognostic Impact of Donor Source on Allogeneic Hematopoietic Stem Cell Transplantation Outcomes in Adults with Chronic Myelomonocytic Leukemia: A Nationwide Retrospective Analysis in Japan Hidehiro Itonaga, Kazunari Aoki, Jun Aoki, Biology of Blood and Marrow Transplantation	2017	33
Additional translocation (8;21)(q22;q22) in a patient with Philadelphia‐positive chronic myelogenous leukaemia in the blastic phase Kensuke Kojima, Masaki Yasukawa, Fumihiko Ishimaru, British Journal of Haematology	1999	30
Familial occurrence of chronic neutrophilic leukaemia Kensuke Kojima, Masaki Yasukawa, Masamichi Hara, British Journal of Haematology	1999	23

Page 1